Sildenafil is actually a potent and selective inhibitor of cGMP-specific phosphodiesterase type five (PDE5), which happens to be liable for degradation of cGMP from the corpus cavernosum. The molecular composition of sildenafil is similar to that of cGMP and functions as a competitive binding agent of PDE5 during the corpus cavernosum, resulting in